000			01563 a2200397 4500
005			20250514224600.0
264		0	_c20060509
008			200605s 0 0 eng d
022			_a0010-7824
024	7		_a10.1016/j.contraception.2004.11.002 _2doi
040			_aNLM _beng _cNLM
100	1		_ale Roux, Paul A
245	0	0	_aLabor induction abortion utilizing trilostane, a 3beta-hydroxysteroid dehydrogenase inhibitor. _h[electronic resource]
260			_bContraception _cMay 2005
300			_a343-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_a3-Hydroxysteroid Dehydrogenases _xantagonists & inhibitors
650	0	4	_aAbortifacient Agents, Nonsteroidal _xadministration & dosage
650	0	4	_aAbortifacient Agents, Steroidal _xadministration & dosage
650	0	4	_aAbortion, Induced
650	0	4	_aAdult
650	0	4	_aAmbulatory Care _xeconomics
650	0	4	_aDihydrotestosterone _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aEnzyme Inhibitors _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMisoprostol _xadministration & dosage
650	0	4	_aPregnancy
650	0	4	_aPregnancy Trimester, Second
650	0	4	_aSouth Africa
650	0	4	_aTime Factors
700	1		_avan der Spuy, Zephne M
773	0		_tContraception _gvol. 71 _gno. 5 _gp. 343-7
856	4	0	_uhttps://doi.org/10.1016/j.contraception.2004.11.002 _zAvailable from publisher's website
999			_c15521636 _d15521636